Meningitis Diagnosis and Treatment Market

Meningitis is the inflammation of meninges (membranes) surrounding the brain and the spinal cord. It causes swelling which triggers symptoms such as fever, headache, and stiff neck. The large patient population and the increasing prevalence of bacterial, viral, and fungal infections contribute to the growth of the market. In addition to this, rising demand for point of care diagnostic services for chronic diseases is expected to fuel the market growth. However, side-effects of antibiotics and steroids and lack of awareness about meningitis are likely to restrain the market growth over the forecast period.

The global meningitis diagnosis and treatment market is growing at a rapid pace. The global meningitis diagnosis and treatment market is expected to reach USD 430.20 million by 2023 from USD 352.34 million in 2017 and is expected to register a CAGR of 3.38% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with an 37.4% share, followed by Europe and Asia-Pacific with shares of 30.3% and 21.8%, respectively.

The market has been segmented based on type, treatment & diagnosis, and end user.

The global meningitis diagnosis and treatment market on the basis of type has been segmented into viral meningitis, bacterial meningitis, fungal meningitis, and others. On the basis of type, the viral meningitis segment accounted for the largest market share of 43.4% in 2017, with a market value of USD 153.04 million, which is projected to register a CAGR of 3.36% during the forecast period. The bacterial meningitis segment accounted for a market share of 40.1% in 2017 and is projected to register the fastest CAGR of 3.54% during the forecast period.

The global meningitis diagnosis and treatment market on the basis of treatment & diagnosis has been segmented into treatment & diagnosis. The treatment segment has been further segmented into antibiotics, steroids, antifungal drugs, and others. The diagnosis segment is further segmented into blood test, imaging techniques, spinal tap (lumbar puncture), and others. On the basis of treatment & diagnosis, the treatment segment accounted for the largest market share of 70.0% in 2017, with a market value of USD 246.53 million, which is projected to register the fastest CAGR of 3.54% during the forecast period.

The market based on end user has been segmented into hospitals & clinics, diagnostic centers, and others. Based on end user, the hospitals & clinics segment accounted for the largest market share of 77.8% in 2017, with a market value of USD 274.12 million, which is projected to register the fastest CAGR of 3.54% over the assessment period.